Lee, N., Zheng, G., Crooks, P., Bardo, M., & Dwoskin, L. (2018). New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. The AAPS Journal, 20(2), 29. https://doi.org/10.1208/s12248-018-0192-y (Original work published 2018)

, Lu, Y., Highland, H., Schürmann, C., Justice, A., Fine, R., … Scientific, G. U. S. (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(5), 766-767. https://doi.org/10.1038/s41588-018-0082-3

, Lu, Y., Highland, H., Schürmann, C., Justice, A., Fine, R., … Scientific, G. U. S. (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(5), 765-766. https://doi.org/10.1038/s41588-018-0050-y

, Lu, Y., Highland, H., Schürmann, C., Justice, A., Fine, R., … Scientific, G. U. S. (2018). Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(1), 26-41. https://doi.org/10.1038/s41588-017-0011-x

Lee, N., Zheng, G., Leggas, M., , , Crooks, P., … Dwoskin, L. (2019). GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine. The Journal of Pharmacology and Experimental Therapeutics, 371(2), 526-543. https://doi.org/10.1124/jpet.119.258699